Ligand targeting allows selective delivery of therapeutic and imaging agents to cancer cells while avoiding collateral damage to healthy tissues. Small-molecule–ligand conjugates more readily ...
Membrane receptors such as GPCRs can typically bind and respond to distinct extracellular ligands 1,2,3. Ligand-binding promiscuity allows a single receptor to control and trigger up to several ...